Aether is seeking to solve the global opioid crisis with a new medicine to treat pain and addiction by modulating a validated drug target with a novel mechanism.
AIVITA Biomedical is a privately held company with a vaccine platform being applied in infectious disease and cancer. We also have assets in retinal degeneration and dermatology.
Allarity Therapeutics is a clinical-stage precision medicine company actively advancing stenoparib, an orally available, small molecule inhibitor for patients with advanced recurrent ovarian cancer. T
...
AllerGene AI Therapeutics is a biotechnology company building first-in-class in vivo mRNA-LNP CAR-T therapies targeting disease-driving mast cells, with the potential to transform the treatment of mas
...
The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines for patients, healthcare sys
...
Alphyn is developing a pipeline of unique multi-target topical therapeutics for dermatology. Our Platform is an impactful innovation because it has multiple bioactive compounds with multiple mechanism
...
The Alzheimer's Drug Discovery Foundation is dedicated to rapidly accelerating the development of drugs to prevent, treat, and cure Alzheimer's disease. The ADDF is the only public charity solely focu
...
Pioneering generative protein design (from the lab of 2024 Nobel Laureate, David Baker) delivers self-assembling, multi-valent/-specific Antibody Cages (AbCs - with 2-30 Ab), that are being developed
...
Arog is a late-stage, privately held U.S. biopharmaceutical company enrolling pivotal studies for crenolanib, an oral TKI with best-in-class profile for FLT3-mutated AML. Preliminary clinical data in
...